Henan Institute of Cardiovascular Epidemiology Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2020
NCT04308551
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Henan Institute of Cardiovascular Epidemiology

Active Ingredients

Drugs in Other Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

k-3920 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 2